Global Pharmaceutical CDMO Supply, Demand and Key Producers, 2023-2029
The global Pharmaceutical CDMO market size is expected to reach $ 216840 million by 2029, rising at a market growth of 7.3% CAGR during the forecast period (2023-2029).
The key service providers of the Pharmaceutical CDMO in the world are Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics and Siegfried, among which the market share of the top three service providers exceeds 10%, and Lonza is the largest service provider. The services provided by global pharmaceutical CDMO are mainly distributed in North America, Europe and China, among which the top three regions account for nearly 60% of the market share, and North America is currently the largest service provider. In terms of its service type, the growth rate of FDF CDMO is relatively fast. At present, the market share of API CDMO is the highest, more than 40%, followed by FDF CDMO, packaging CDMO and clinical CDMO. In terms of its application, pharmaceutical company are the largest application field, with a market share of more than 60%, followed by biotechnology company.
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
Contract Pharmaceutical Manufacturing is part of CDMO, refers to accept commissioned from pharmaceutical companies, provide the service about API production, FDF production, packaging.
Pharmaceutical companies are likely to outsource a wide range of manufacturing related activities including – primary and secondary packaging, formulation, active ingredient manufacturing, labeling, clinical supplies, sterilization, manufacturing of chemical intermediates, etc. CDMOs support pharmaceutical companies at all stages of the process of making medicines: by providing services in the research and development stages, by offering support in manufacturing, and by providing formulating and finishing processes.
This report studies the global Pharmaceutical CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical CDMO total market, 2018-2029, (USD Million)
Global Pharmaceutical CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical CDMO total market, key domestic companies and share, (USD Million)
Global Pharmaceutical CDMO revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pharmaceutical CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried and FUJIFILM Diosynth Biotechnologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical CDMO Market, By Region:
1. How big is the global Pharmaceutical CDMO market?
2. What is the demand of the global Pharmaceutical CDMO market?
3. What is the year over year growth of the global Pharmaceutical CDMO market?
4. What is the total value of the global Pharmaceutical CDMO market?
5. Who are the major players in the global Pharmaceutical CDMO market?
6. What are the growth factors driving the market demand?
The key service providers of the Pharmaceutical CDMO in the world are Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics and Siegfried, among which the market share of the top three service providers exceeds 10%, and Lonza is the largest service provider. The services provided by global pharmaceutical CDMO are mainly distributed in North America, Europe and China, among which the top three regions account for nearly 60% of the market share, and North America is currently the largest service provider. In terms of its service type, the growth rate of FDF CDMO is relatively fast. At present, the market share of API CDMO is the highest, more than 40%, followed by FDF CDMO, packaging CDMO and clinical CDMO. In terms of its application, pharmaceutical company are the largest application field, with a market share of more than 60%, followed by biotechnology company.
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
Contract Pharmaceutical Manufacturing is part of CDMO, refers to accept commissioned from pharmaceutical companies, provide the service about API production, FDF production, packaging.
Pharmaceutical companies are likely to outsource a wide range of manufacturing related activities including – primary and secondary packaging, formulation, active ingredient manufacturing, labeling, clinical supplies, sterilization, manufacturing of chemical intermediates, etc. CDMOs support pharmaceutical companies at all stages of the process of making medicines: by providing services in the research and development stages, by offering support in manufacturing, and by providing formulating and finishing processes.
This report studies the global Pharmaceutical CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical CDMO total market, 2018-2029, (USD Million)
Global Pharmaceutical CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical CDMO total market, key domestic companies and share, (USD Million)
Global Pharmaceutical CDMO revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pharmaceutical CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried and FUJIFILM Diosynth Biotechnologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- API CDMO
- FDF CDMO
- Packaging CDMO
- Clinical CDMO
- Pharmaceutical Company
- Biotechnology Company
- Other
- Lonza
- Catalent
- Thermo Fisher Scientific
- Samsung Biologics
- Fareva
- WuXi AppTech
- WuXi Biologics
- Siegfried
- FUJIFILM Diosynth Biotechnologies
- Asymchem
- Pfizer CentreOne
- Delpharm
- Recipharm
- AGC Pharma Chemicals
- Boehringer Ingelheim
- Vetter
- Curia
- Aenova
- Porton
- Piramal
- Strides Pharma
- NextPharma
- Famar
- Jubilant
- Alcami
- Euroapi
- Eurofins
- Avid Bioservices
- BioVectra
- CPL
1. How big is the global Pharmaceutical CDMO market?
2. What is the demand of the global Pharmaceutical CDMO market?
3. What is the year over year growth of the global Pharmaceutical CDMO market?
4. What is the total value of the global Pharmaceutical CDMO market?
5. Who are the major players in the global Pharmaceutical CDMO market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pharmaceutical CDMO Introduction
1.2 World Pharmaceutical CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical CDMO Market Size (2018-2029)
1.3.3 China Pharmaceutical CDMO Market Size (2018-2029)
1.3.4 Europe Pharmaceutical CDMO Market Size (2018-2029)
1.3.5 Japan Pharmaceutical CDMO Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical CDMO Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical CDMO Market Size (2018-2029)
1.3.8 India Pharmaceutical CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pharmaceutical CDMO Consumption Value (2018-2029)
2.2 World Pharmaceutical CDMO Consumption Value by Region
2.2.1 World Pharmaceutical CDMO Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical CDMO Consumption Value (2018-2029)
2.4 China Pharmaceutical CDMO Consumption Value (2018-2029)
2.5 Europe Pharmaceutical CDMO Consumption Value (2018-2029)
2.6 Japan Pharmaceutical CDMO Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical CDMO Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical CDMO Consumption Value (2018-2029)
2.9 India Pharmaceutical CDMO Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical CDMO in 2022
3.3 Pharmaceutical CDMO Company Evaluation Quadrant
3.4 Pharmaceutical CDMO Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical CDMO Market: Region Footprint
3.4.2 Pharmaceutical CDMO Market: Company Product Type Footprint
3.4.3 Pharmaceutical CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical CDMO Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical CDMO Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical CDMO Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 API CDMO
5.2.2 FDF CDMO
5.2.3 Packaging CDMO
5.2.4 Clinical CDMO
5.3 Market Segment by Type
5.3.1 World Pharmaceutical CDMO Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical CDMO Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Pharmaceutical CDMO Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical CDMO Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Pharmaceutical CDMO Product and Services
7.1.4 Lonza Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Catalent
7.2.1 Catalent Details
7.2.2 Catalent Major Business
7.2.3 Catalent Pharmaceutical CDMO Product and Services
7.2.4 Catalent Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Catalent Recent Developments/Updates
7.2.6 Catalent Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Pharmaceutical CDMO Product and Services
7.3.4 Thermo Fisher Scientific Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Samsung Biologics
7.4.1 Samsung Biologics Details
7.4.2 Samsung Biologics Major Business
7.4.3 Samsung Biologics Pharmaceutical CDMO Product and Services
7.4.4 Samsung Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Samsung Biologics Recent Developments/Updates
7.4.6 Samsung Biologics Competitive Strengths & Weaknesses
7.5 Fareva
7.5.1 Fareva Details
7.5.2 Fareva Major Business
7.5.3 Fareva Pharmaceutical CDMO Product and Services
7.5.4 Fareva Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Fareva Recent Developments/Updates
7.5.6 Fareva Competitive Strengths & Weaknesses
7.6 WuXi AppTech
7.6.1 WuXi AppTech Details
7.6.2 WuXi AppTech Major Business
7.6.3 WuXi AppTech Pharmaceutical CDMO Product and Services
7.6.4 WuXi AppTech Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 WuXi AppTech Recent Developments/Updates
7.6.6 WuXi AppTech Competitive Strengths & Weaknesses
7.7 WuXi Biologics
7.7.1 WuXi Biologics Details
7.7.2 WuXi Biologics Major Business
7.7.3 WuXi Biologics Pharmaceutical CDMO Product and Services
7.7.4 WuXi Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 WuXi Biologics Recent Developments/Updates
7.7.6 WuXi Biologics Competitive Strengths & Weaknesses
7.8 Siegfried
7.8.1 Siegfried Details
7.8.2 Siegfried Major Business
7.8.3 Siegfried Pharmaceutical CDMO Product and Services
7.8.4 Siegfried Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Siegfried Recent Developments/Updates
7.8.6 Siegfried Competitive Strengths & Weaknesses
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Details
7.9.2 FUJIFILM Diosynth Biotechnologies Major Business
7.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product and Services
7.9.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.9.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.10 Asymchem
7.10.1 Asymchem Details
7.10.2 Asymchem Major Business
7.10.3 Asymchem Pharmaceutical CDMO Product and Services
7.10.4 Asymchem Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Asymchem Recent Developments/Updates
7.10.6 Asymchem Competitive Strengths & Weaknesses
7.11 Pfizer CentreOne
7.11.1 Pfizer CentreOne Details
7.11.2 Pfizer CentreOne Major Business
7.11.3 Pfizer CentreOne Pharmaceutical CDMO Product and Services
7.11.4 Pfizer CentreOne Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Pfizer CentreOne Recent Developments/Updates
7.11.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.12 Delpharm
7.12.1 Delpharm Details
7.12.2 Delpharm Major Business
7.12.3 Delpharm Pharmaceutical CDMO Product and Services
7.12.4 Delpharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Delpharm Recent Developments/Updates
7.12.6 Delpharm Competitive Strengths & Weaknesses
7.13 Recipharm
7.13.1 Recipharm Details
7.13.2 Recipharm Major Business
7.13.3 Recipharm Pharmaceutical CDMO Product and Services
7.13.4 Recipharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Recipharm Recent Developments/Updates
7.13.6 Recipharm Competitive Strengths & Weaknesses
7.14 AGC Pharma Chemicals
7.14.1 AGC Pharma Chemicals Details
7.14.2 AGC Pharma Chemicals Major Business
7.14.3 AGC Pharma Chemicals Pharmaceutical CDMO Product and Services
7.14.4 AGC Pharma Chemicals Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 AGC Pharma Chemicals Recent Developments/Updates
7.14.6 AGC Pharma Chemicals Competitive Strengths & Weaknesses
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Details
7.15.2 Boehringer Ingelheim Major Business
7.15.3 Boehringer Ingelheim Pharmaceutical CDMO Product and Services
7.15.4 Boehringer Ingelheim Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Boehringer Ingelheim Recent Developments/Updates
7.15.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.16 Vetter
7.16.1 Vetter Details
7.16.2 Vetter Major Business
7.16.3 Vetter Pharmaceutical CDMO Product and Services
7.16.4 Vetter Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Vetter Recent Developments/Updates
7.16.6 Vetter Competitive Strengths & Weaknesses
7.17 Curia
7.17.1 Curia Details
7.17.2 Curia Major Business
7.17.3 Curia Pharmaceutical CDMO Product and Services
7.17.4 Curia Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Curia Recent Developments/Updates
7.17.6 Curia Competitive Strengths & Weaknesses
7.18 Aenova
7.18.1 Aenova Details
7.18.2 Aenova Major Business
7.18.3 Aenova Pharmaceutical CDMO Product and Services
7.18.4 Aenova Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Aenova Recent Developments/Updates
7.18.6 Aenova Competitive Strengths & Weaknesses
7.19 Porton
7.19.1 Porton Details
7.19.2 Porton Major Business
7.19.3 Porton Pharmaceutical CDMO Product and Services
7.19.4 Porton Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Porton Recent Developments/Updates
7.19.6 Porton Competitive Strengths & Weaknesses
7.20 Piramal
7.20.1 Piramal Details
7.20.2 Piramal Major Business
7.20.3 Piramal Pharmaceutical CDMO Product and Services
7.20.4 Piramal Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Piramal Recent Developments/Updates
7.20.6 Piramal Competitive Strengths & Weaknesses
7.21 Strides Pharma
7.21.1 Strides Pharma Details
7.21.2 Strides Pharma Major Business
7.21.3 Strides Pharma Pharmaceutical CDMO Product and Services
7.21.4 Strides Pharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Strides Pharma Recent Developments/Updates
7.21.6 Strides Pharma Competitive Strengths & Weaknesses
7.22 NextPharma
7.22.1 NextPharma Details
7.22.2 NextPharma Major Business
7.22.3 NextPharma Pharmaceutical CDMO Product and Services
7.22.4 NextPharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 NextPharma Recent Developments/Updates
7.22.6 NextPharma Competitive Strengths & Weaknesses
7.23 Famar
7.23.1 Famar Details
7.23.2 Famar Major Business
7.23.3 Famar Pharmaceutical CDMO Product and Services
7.23.4 Famar Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Famar Recent Developments/Updates
7.23.6 Famar Competitive Strengths & Weaknesses
7.24 Jubilant
7.24.1 Jubilant Details
7.24.2 Jubilant Major Business
7.24.3 Jubilant Pharmaceutical CDMO Product and Services
7.24.4 Jubilant Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Jubilant Recent Developments/Updates
7.24.6 Jubilant Competitive Strengths & Weaknesses
7.25 Alcami
7.25.1 Alcami Details
7.25.2 Alcami Major Business
7.25.3 Alcami Pharmaceutical CDMO Product and Services
7.25.4 Alcami Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Alcami Recent Developments/Updates
7.25.6 Alcami Competitive Strengths & Weaknesses
7.26 Euroapi
7.26.1 Euroapi Details
7.26.2 Euroapi Major Business
7.26.3 Euroapi Pharmaceutical CDMO Product and Services
7.26.4 Euroapi Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Euroapi Recent Developments/Updates
7.26.6 Euroapi Competitive Strengths & Weaknesses
7.27 Eurofins
7.27.1 Eurofins Details
7.27.2 Eurofins Major Business
7.27.3 Eurofins Pharmaceutical CDMO Product and Services
7.27.4 Eurofins Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.27.5 Eurofins Recent Developments/Updates
7.27.6 Eurofins Competitive Strengths & Weaknesses
7.28 Avid Bioservices
7.28.1 Avid Bioservices Details
7.28.2 Avid Bioservices Major Business
7.28.3 Avid Bioservices Pharmaceutical CDMO Product and Services
7.28.4 Avid Bioservices Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.28.5 Avid Bioservices Recent Developments/Updates
7.28.6 Avid Bioservices Competitive Strengths & Weaknesses
7.29 BioVectra
7.29.1 BioVectra Details
7.29.2 BioVectra Major Business
7.29.3 BioVectra Pharmaceutical CDMO Product and Services
7.29.4 BioVectra Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.29.5 BioVectra Recent Developments/Updates
7.29.6 BioVectra Competitive Strengths & Weaknesses
7.30 CPL
7.30.1 CPL Details
7.30.2 CPL Major Business
7.30.3 CPL Pharmaceutical CDMO Product and Services
7.30.4 CPL Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.30.5 CPL Recent Developments/Updates
7.30.6 CPL Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pharmaceutical CDMO Industry Chain
8.2 Pharmaceutical CDMO Upstream Analysis
8.3 Pharmaceutical CDMO Midstream Analysis
8.4 Pharmaceutical CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pharmaceutical CDMO Introduction
1.2 World Pharmaceutical CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical CDMO Market Size (2018-2029)
1.3.3 China Pharmaceutical CDMO Market Size (2018-2029)
1.3.4 Europe Pharmaceutical CDMO Market Size (2018-2029)
1.3.5 Japan Pharmaceutical CDMO Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical CDMO Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical CDMO Market Size (2018-2029)
1.3.8 India Pharmaceutical CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pharmaceutical CDMO Consumption Value (2018-2029)
2.2 World Pharmaceutical CDMO Consumption Value by Region
2.2.1 World Pharmaceutical CDMO Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical CDMO Consumption Value (2018-2029)
2.4 China Pharmaceutical CDMO Consumption Value (2018-2029)
2.5 Europe Pharmaceutical CDMO Consumption Value (2018-2029)
2.6 Japan Pharmaceutical CDMO Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical CDMO Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical CDMO Consumption Value (2018-2029)
2.9 India Pharmaceutical CDMO Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical CDMO in 2022
3.3 Pharmaceutical CDMO Company Evaluation Quadrant
3.4 Pharmaceutical CDMO Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical CDMO Market: Region Footprint
3.4.2 Pharmaceutical CDMO Market: Company Product Type Footprint
3.4.3 Pharmaceutical CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical CDMO Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical CDMO Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical CDMO Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 API CDMO
5.2.2 FDF CDMO
5.2.3 Packaging CDMO
5.2.4 Clinical CDMO
5.3 Market Segment by Type
5.3.1 World Pharmaceutical CDMO Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical CDMO Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Pharmaceutical CDMO Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical CDMO Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Pharmaceutical CDMO Product and Services
7.1.4 Lonza Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Catalent
7.2.1 Catalent Details
7.2.2 Catalent Major Business
7.2.3 Catalent Pharmaceutical CDMO Product and Services
7.2.4 Catalent Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Catalent Recent Developments/Updates
7.2.6 Catalent Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Pharmaceutical CDMO Product and Services
7.3.4 Thermo Fisher Scientific Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Samsung Biologics
7.4.1 Samsung Biologics Details
7.4.2 Samsung Biologics Major Business
7.4.3 Samsung Biologics Pharmaceutical CDMO Product and Services
7.4.4 Samsung Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Samsung Biologics Recent Developments/Updates
7.4.6 Samsung Biologics Competitive Strengths & Weaknesses
7.5 Fareva
7.5.1 Fareva Details
7.5.2 Fareva Major Business
7.5.3 Fareva Pharmaceutical CDMO Product and Services
7.5.4 Fareva Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Fareva Recent Developments/Updates
7.5.6 Fareva Competitive Strengths & Weaknesses
7.6 WuXi AppTech
7.6.1 WuXi AppTech Details
7.6.2 WuXi AppTech Major Business
7.6.3 WuXi AppTech Pharmaceutical CDMO Product and Services
7.6.4 WuXi AppTech Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 WuXi AppTech Recent Developments/Updates
7.6.6 WuXi AppTech Competitive Strengths & Weaknesses
7.7 WuXi Biologics
7.7.1 WuXi Biologics Details
7.7.2 WuXi Biologics Major Business
7.7.3 WuXi Biologics Pharmaceutical CDMO Product and Services
7.7.4 WuXi Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 WuXi Biologics Recent Developments/Updates
7.7.6 WuXi Biologics Competitive Strengths & Weaknesses
7.8 Siegfried
7.8.1 Siegfried Details
7.8.2 Siegfried Major Business
7.8.3 Siegfried Pharmaceutical CDMO Product and Services
7.8.4 Siegfried Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Siegfried Recent Developments/Updates
7.8.6 Siegfried Competitive Strengths & Weaknesses
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Details
7.9.2 FUJIFILM Diosynth Biotechnologies Major Business
7.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product and Services
7.9.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.9.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.10 Asymchem
7.10.1 Asymchem Details
7.10.2 Asymchem Major Business
7.10.3 Asymchem Pharmaceutical CDMO Product and Services
7.10.4 Asymchem Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Asymchem Recent Developments/Updates
7.10.6 Asymchem Competitive Strengths & Weaknesses
7.11 Pfizer CentreOne
7.11.1 Pfizer CentreOne Details
7.11.2 Pfizer CentreOne Major Business
7.11.3 Pfizer CentreOne Pharmaceutical CDMO Product and Services
7.11.4 Pfizer CentreOne Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Pfizer CentreOne Recent Developments/Updates
7.11.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.12 Delpharm
7.12.1 Delpharm Details
7.12.2 Delpharm Major Business
7.12.3 Delpharm Pharmaceutical CDMO Product and Services
7.12.4 Delpharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Delpharm Recent Developments/Updates
7.12.6 Delpharm Competitive Strengths & Weaknesses
7.13 Recipharm
7.13.1 Recipharm Details
7.13.2 Recipharm Major Business
7.13.3 Recipharm Pharmaceutical CDMO Product and Services
7.13.4 Recipharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Recipharm Recent Developments/Updates
7.13.6 Recipharm Competitive Strengths & Weaknesses
7.14 AGC Pharma Chemicals
7.14.1 AGC Pharma Chemicals Details
7.14.2 AGC Pharma Chemicals Major Business
7.14.3 AGC Pharma Chemicals Pharmaceutical CDMO Product and Services
7.14.4 AGC Pharma Chemicals Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 AGC Pharma Chemicals Recent Developments/Updates
7.14.6 AGC Pharma Chemicals Competitive Strengths & Weaknesses
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Details
7.15.2 Boehringer Ingelheim Major Business
7.15.3 Boehringer Ingelheim Pharmaceutical CDMO Product and Services
7.15.4 Boehringer Ingelheim Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Boehringer Ingelheim Recent Developments/Updates
7.15.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.16 Vetter
7.16.1 Vetter Details
7.16.2 Vetter Major Business
7.16.3 Vetter Pharmaceutical CDMO Product and Services
7.16.4 Vetter Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Vetter Recent Developments/Updates
7.16.6 Vetter Competitive Strengths & Weaknesses
7.17 Curia
7.17.1 Curia Details
7.17.2 Curia Major Business
7.17.3 Curia Pharmaceutical CDMO Product and Services
7.17.4 Curia Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Curia Recent Developments/Updates
7.17.6 Curia Competitive Strengths & Weaknesses
7.18 Aenova
7.18.1 Aenova Details
7.18.2 Aenova Major Business
7.18.3 Aenova Pharmaceutical CDMO Product and Services
7.18.4 Aenova Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Aenova Recent Developments/Updates
7.18.6 Aenova Competitive Strengths & Weaknesses
7.19 Porton
7.19.1 Porton Details
7.19.2 Porton Major Business
7.19.3 Porton Pharmaceutical CDMO Product and Services
7.19.4 Porton Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Porton Recent Developments/Updates
7.19.6 Porton Competitive Strengths & Weaknesses
7.20 Piramal
7.20.1 Piramal Details
7.20.2 Piramal Major Business
7.20.3 Piramal Pharmaceutical CDMO Product and Services
7.20.4 Piramal Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Piramal Recent Developments/Updates
7.20.6 Piramal Competitive Strengths & Weaknesses
7.21 Strides Pharma
7.21.1 Strides Pharma Details
7.21.2 Strides Pharma Major Business
7.21.3 Strides Pharma Pharmaceutical CDMO Product and Services
7.21.4 Strides Pharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 Strides Pharma Recent Developments/Updates
7.21.6 Strides Pharma Competitive Strengths & Weaknesses
7.22 NextPharma
7.22.1 NextPharma Details
7.22.2 NextPharma Major Business
7.22.3 NextPharma Pharmaceutical CDMO Product and Services
7.22.4 NextPharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.22.5 NextPharma Recent Developments/Updates
7.22.6 NextPharma Competitive Strengths & Weaknesses
7.23 Famar
7.23.1 Famar Details
7.23.2 Famar Major Business
7.23.3 Famar Pharmaceutical CDMO Product and Services
7.23.4 Famar Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.23.5 Famar Recent Developments/Updates
7.23.6 Famar Competitive Strengths & Weaknesses
7.24 Jubilant
7.24.1 Jubilant Details
7.24.2 Jubilant Major Business
7.24.3 Jubilant Pharmaceutical CDMO Product and Services
7.24.4 Jubilant Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.24.5 Jubilant Recent Developments/Updates
7.24.6 Jubilant Competitive Strengths & Weaknesses
7.25 Alcami
7.25.1 Alcami Details
7.25.2 Alcami Major Business
7.25.3 Alcami Pharmaceutical CDMO Product and Services
7.25.4 Alcami Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.25.5 Alcami Recent Developments/Updates
7.25.6 Alcami Competitive Strengths & Weaknesses
7.26 Euroapi
7.26.1 Euroapi Details
7.26.2 Euroapi Major Business
7.26.3 Euroapi Pharmaceutical CDMO Product and Services
7.26.4 Euroapi Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.26.5 Euroapi Recent Developments/Updates
7.26.6 Euroapi Competitive Strengths & Weaknesses
7.27 Eurofins
7.27.1 Eurofins Details
7.27.2 Eurofins Major Business
7.27.3 Eurofins Pharmaceutical CDMO Product and Services
7.27.4 Eurofins Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.27.5 Eurofins Recent Developments/Updates
7.27.6 Eurofins Competitive Strengths & Weaknesses
7.28 Avid Bioservices
7.28.1 Avid Bioservices Details
7.28.2 Avid Bioservices Major Business
7.28.3 Avid Bioservices Pharmaceutical CDMO Product and Services
7.28.4 Avid Bioservices Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.28.5 Avid Bioservices Recent Developments/Updates
7.28.6 Avid Bioservices Competitive Strengths & Weaknesses
7.29 BioVectra
7.29.1 BioVectra Details
7.29.2 BioVectra Major Business
7.29.3 BioVectra Pharmaceutical CDMO Product and Services
7.29.4 BioVectra Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.29.5 BioVectra Recent Developments/Updates
7.29.6 BioVectra Competitive Strengths & Weaknesses
7.30 CPL
7.30.1 CPL Details
7.30.2 CPL Major Business
7.30.3 CPL Pharmaceutical CDMO Product and Services
7.30.4 CPL Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.30.5 CPL Recent Developments/Updates
7.30.6 CPL Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pharmaceutical CDMO Industry Chain
8.2 Pharmaceutical CDMO Upstream Analysis
8.3 Pharmaceutical CDMO Midstream Analysis
8.4 Pharmaceutical CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pharmaceutical CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical CDMO Players in 2022
Table 12. World Pharmaceutical CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical CDMO Player
Table 15. Pharmaceutical CDMO Market: Company Product Type Footprint
Table 16. Pharmaceutical CDMO Market: Company Product Application Footprint
Table 17. Pharmaceutical CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical CDMO Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical CDMO Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Pharmaceutical CDMO Product and Services
Table 38. Lonza Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Catalent Basic Information, Area Served and Competitors
Table 42. Catalent Major Business
Table 43. Catalent Pharmaceutical CDMO Product and Services
Table 44. Catalent Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Catalent Recent Developments/Updates
Table 46. Catalent Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Pharmaceutical CDMO Product and Services
Table 50. Thermo Fisher Scientific Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Samsung Biologics Basic Information, Area Served and Competitors
Table 54. Samsung Biologics Major Business
Table 55. Samsung Biologics Pharmaceutical CDMO Product and Services
Table 56. Samsung Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Samsung Biologics Recent Developments/Updates
Table 58. Samsung Biologics Competitive Strengths & Weaknesses
Table 59. Fareva Basic Information, Area Served and Competitors
Table 60. Fareva Major Business
Table 61. Fareva Pharmaceutical CDMO Product and Services
Table 62. Fareva Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Fareva Recent Developments/Updates
Table 64. Fareva Competitive Strengths & Weaknesses
Table 65. WuXi AppTech Basic Information, Area Served and Competitors
Table 66. WuXi AppTech Major Business
Table 67. WuXi AppTech Pharmaceutical CDMO Product and Services
Table 68. WuXi AppTech Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. WuXi AppTech Recent Developments/Updates
Table 70. WuXi AppTech Competitive Strengths & Weaknesses
Table 71. WuXi Biologics Basic Information, Area Served and Competitors
Table 72. WuXi Biologics Major Business
Table 73. WuXi Biologics Pharmaceutical CDMO Product and Services
Table 74. WuXi Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. WuXi Biologics Recent Developments/Updates
Table 76. WuXi Biologics Competitive Strengths & Weaknesses
Table 77. Siegfried Basic Information, Area Served and Competitors
Table 78. Siegfried Major Business
Table 79. Siegfried Pharmaceutical CDMO Product and Services
Table 80. Siegfried Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Siegfried Recent Developments/Updates
Table 82. Siegfried Competitive Strengths & Weaknesses
Table 83. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 84. FUJIFILM Diosynth Biotechnologies Major Business
Table 85. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product and Services
Table 86. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 88. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 89. Asymchem Basic Information, Area Served and Competitors
Table 90. Asymchem Major Business
Table 91. Asymchem Pharmaceutical CDMO Product and Services
Table 92. Asymchem Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Asymchem Recent Developments/Updates
Table 94. Asymchem Competitive Strengths & Weaknesses
Table 95. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 96. Pfizer CentreOne Major Business
Table 97. Pfizer CentreOne Pharmaceutical CDMO Product and Services
Table 98. Pfizer CentreOne Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Pfizer CentreOne Recent Developments/Updates
Table 100. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 101. Delpharm Basic Information, Area Served and Competitors
Table 102. Delpharm Major Business
Table 103. Delpharm Pharmaceutical CDMO Product and Services
Table 104. Delpharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Delpharm Recent Developments/Updates
Table 106. Delpharm Competitive Strengths & Weaknesses
Table 107. Recipharm Basic Information, Area Served and Competitors
Table 108. Recipharm Major Business
Table 109. Recipharm Pharmaceutical CDMO Product and Services
Table 110. Recipharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Recipharm Recent Developments/Updates
Table 112. Recipharm Competitive Strengths & Weaknesses
Table 113. AGC Pharma Chemicals Basic Information, Area Served and Competitors
Table 114. AGC Pharma Chemicals Major Business
Table 115. AGC Pharma Chemicals Pharmaceutical CDMO Product and Services
Table 116. AGC Pharma Chemicals Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. AGC Pharma Chemicals Recent Developments/Updates
Table 118. AGC Pharma Chemicals Competitive Strengths & Weaknesses
Table 119. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 120. Boehringer Ingelheim Major Business
Table 121. Boehringer Ingelheim Pharmaceutical CDMO Product and Services
Table 122. Boehringer Ingelheim Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Boehringer Ingelheim Recent Developments/Updates
Table 124. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 125. Vetter Basic Information, Area Served and Competitors
Table 126. Vetter Major Business
Table 127. Vetter Pharmaceutical CDMO Product and Services
Table 128. Vetter Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Vetter Recent Developments/Updates
Table 130. Vetter Competitive Strengths & Weaknesses
Table 131. Curia Basic Information, Area Served and Competitors
Table 132. Curia Major Business
Table 133. Curia Pharmaceutical CDMO Product and Services
Table 134. Curia Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Curia Recent Developments/Updates
Table 136. Curia Competitive Strengths & Weaknesses
Table 137. Aenova Basic Information, Area Served and Competitors
Table 138. Aenova Major Business
Table 139. Aenova Pharmaceutical CDMO Product and Services
Table 140. Aenova Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Aenova Recent Developments/Updates
Table 142. Aenova Competitive Strengths & Weaknesses
Table 143. Porton Basic Information, Area Served and Competitors
Table 144. Porton Major Business
Table 145. Porton Pharmaceutical CDMO Product and Services
Table 146. Porton Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Porton Recent Developments/Updates
Table 148. Porton Competitive Strengths & Weaknesses
Table 149. Piramal Basic Information, Area Served and Competitors
Table 150. Piramal Major Business
Table 151. Piramal Pharmaceutical CDMO Product and Services
Table 152. Piramal Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Piramal Recent Developments/Updates
Table 154. Piramal Competitive Strengths & Weaknesses
Table 155. Strides Pharma Basic Information, Area Served and Competitors
Table 156. Strides Pharma Major Business
Table 157. Strides Pharma Pharmaceutical CDMO Product and Services
Table 158. Strides Pharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Strides Pharma Recent Developments/Updates
Table 160. Strides Pharma Competitive Strengths & Weaknesses
Table 161. NextPharma Basic Information, Area Served and Competitors
Table 162. NextPharma Major Business
Table 163. NextPharma Pharmaceutical CDMO Product and Services
Table 164. NextPharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. NextPharma Recent Developments/Updates
Table 166. NextPharma Competitive Strengths & Weaknesses
Table 167. Famar Basic Information, Area Served and Competitors
Table 168. Famar Major Business
Table 169. Famar Pharmaceutical CDMO Product and Services
Table 170. Famar Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Famar Recent Developments/Updates
Table 172. Famar Competitive Strengths & Weaknesses
Table 173. Jubilant Basic Information, Area Served and Competitors
Table 174. Jubilant Major Business
Table 175. Jubilant Pharmaceutical CDMO Product and Services
Table 176. Jubilant Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Jubilant Recent Developments/Updates
Table 178. Jubilant Competitive Strengths & Weaknesses
Table 179. Alcami Basic Information, Area Served and Competitors
Table 180. Alcami Major Business
Table 181. Alcami Pharmaceutical CDMO Product and Services
Table 182. Alcami Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. Alcami Recent Developments/Updates
Table 184. Alcami Competitive Strengths & Weaknesses
Table 185. Euroapi Basic Information, Area Served and Competitors
Table 186. Euroapi Major Business
Table 187. Euroapi Pharmaceutical CDMO Product and Services
Table 188. Euroapi Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 189. Euroapi Recent Developments/Updates
Table 190. Euroapi Competitive Strengths & Weaknesses
Table 191. Eurofins Basic Information, Area Served and Competitors
Table 192. Eurofins Major Business
Table 193. Eurofins Pharmaceutical CDMO Product and Services
Table 194. Eurofins Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 195. Eurofins Recent Developments/Updates
Table 196. Eurofins Competitive Strengths & Weaknesses
Table 197. Avid Bioservices Basic Information, Area Served and Competitors
Table 198. Avid Bioservices Major Business
Table 199. Avid Bioservices Pharmaceutical CDMO Product and Services
Table 200. Avid Bioservices Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 201. Avid Bioservices Recent Developments/Updates
Table 202. Avid Bioservices Competitive Strengths & Weaknesses
Table 203. BioVectra Basic Information, Area Served and Competitors
Table 204. BioVectraMajor Business
Table 205. BioVectra Pharmaceutical CDMO Product and Services
Table 206. BioVectra Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 207. BioVectra Recent Developments/Updates
Table 208. CPL Basic Information, Area Served and Competitors
Table 209. CPL Major Business
Table 210. CPL Pharmaceutical CDMO Product and Services
Table 211. CPL Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 212. Global Key Players of Pharmaceutical CDMO Upstream (Raw Materials)
Table 213. Pharmaceutical CDMO Typical Customers
Table 1. World Pharmaceutical CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical CDMO Players in 2022
Table 12. World Pharmaceutical CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical CDMO Player
Table 15. Pharmaceutical CDMO Market: Company Product Type Footprint
Table 16. Pharmaceutical CDMO Market: Company Product Application Footprint
Table 17. Pharmaceutical CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical CDMO Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical CDMO Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Pharmaceutical CDMO Product and Services
Table 38. Lonza Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Catalent Basic Information, Area Served and Competitors
Table 42. Catalent Major Business
Table 43. Catalent Pharmaceutical CDMO Product and Services
Table 44. Catalent Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Catalent Recent Developments/Updates
Table 46. Catalent Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Pharmaceutical CDMO Product and Services
Table 50. Thermo Fisher Scientific Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Samsung Biologics Basic Information, Area Served and Competitors
Table 54. Samsung Biologics Major Business
Table 55. Samsung Biologics Pharmaceutical CDMO Product and Services
Table 56. Samsung Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Samsung Biologics Recent Developments/Updates
Table 58. Samsung Biologics Competitive Strengths & Weaknesses
Table 59. Fareva Basic Information, Area Served and Competitors
Table 60. Fareva Major Business
Table 61. Fareva Pharmaceutical CDMO Product and Services
Table 62. Fareva Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Fareva Recent Developments/Updates
Table 64. Fareva Competitive Strengths & Weaknesses
Table 65. WuXi AppTech Basic Information, Area Served and Competitors
Table 66. WuXi AppTech Major Business
Table 67. WuXi AppTech Pharmaceutical CDMO Product and Services
Table 68. WuXi AppTech Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. WuXi AppTech Recent Developments/Updates
Table 70. WuXi AppTech Competitive Strengths & Weaknesses
Table 71. WuXi Biologics Basic Information, Area Served and Competitors
Table 72. WuXi Biologics Major Business
Table 73. WuXi Biologics Pharmaceutical CDMO Product and Services
Table 74. WuXi Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. WuXi Biologics Recent Developments/Updates
Table 76. WuXi Biologics Competitive Strengths & Weaknesses
Table 77. Siegfried Basic Information, Area Served and Competitors
Table 78. Siegfried Major Business
Table 79. Siegfried Pharmaceutical CDMO Product and Services
Table 80. Siegfried Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Siegfried Recent Developments/Updates
Table 82. Siegfried Competitive Strengths & Weaknesses
Table 83. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 84. FUJIFILM Diosynth Biotechnologies Major Business
Table 85. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product and Services
Table 86. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 88. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 89. Asymchem Basic Information, Area Served and Competitors
Table 90. Asymchem Major Business
Table 91. Asymchem Pharmaceutical CDMO Product and Services
Table 92. Asymchem Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Asymchem Recent Developments/Updates
Table 94. Asymchem Competitive Strengths & Weaknesses
Table 95. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 96. Pfizer CentreOne Major Business
Table 97. Pfizer CentreOne Pharmaceutical CDMO Product and Services
Table 98. Pfizer CentreOne Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Pfizer CentreOne Recent Developments/Updates
Table 100. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 101. Delpharm Basic Information, Area Served and Competitors
Table 102. Delpharm Major Business
Table 103. Delpharm Pharmaceutical CDMO Product and Services
Table 104. Delpharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Delpharm Recent Developments/Updates
Table 106. Delpharm Competitive Strengths & Weaknesses
Table 107. Recipharm Basic Information, Area Served and Competitors
Table 108. Recipharm Major Business
Table 109. Recipharm Pharmaceutical CDMO Product and Services
Table 110. Recipharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Recipharm Recent Developments/Updates
Table 112. Recipharm Competitive Strengths & Weaknesses
Table 113. AGC Pharma Chemicals Basic Information, Area Served and Competitors
Table 114. AGC Pharma Chemicals Major Business
Table 115. AGC Pharma Chemicals Pharmaceutical CDMO Product and Services
Table 116. AGC Pharma Chemicals Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. AGC Pharma Chemicals Recent Developments/Updates
Table 118. AGC Pharma Chemicals Competitive Strengths & Weaknesses
Table 119. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 120. Boehringer Ingelheim Major Business
Table 121. Boehringer Ingelheim Pharmaceutical CDMO Product and Services
Table 122. Boehringer Ingelheim Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Boehringer Ingelheim Recent Developments/Updates
Table 124. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 125. Vetter Basic Information, Area Served and Competitors
Table 126. Vetter Major Business
Table 127. Vetter Pharmaceutical CDMO Product and Services
Table 128. Vetter Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Vetter Recent Developments/Updates
Table 130. Vetter Competitive Strengths & Weaknesses
Table 131. Curia Basic Information, Area Served and Competitors
Table 132. Curia Major Business
Table 133. Curia Pharmaceutical CDMO Product and Services
Table 134. Curia Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Curia Recent Developments/Updates
Table 136. Curia Competitive Strengths & Weaknesses
Table 137. Aenova Basic Information, Area Served and Competitors
Table 138. Aenova Major Business
Table 139. Aenova Pharmaceutical CDMO Product and Services
Table 140. Aenova Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Aenova Recent Developments/Updates
Table 142. Aenova Competitive Strengths & Weaknesses
Table 143. Porton Basic Information, Area Served and Competitors
Table 144. Porton Major Business
Table 145. Porton Pharmaceutical CDMO Product and Services
Table 146. Porton Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Porton Recent Developments/Updates
Table 148. Porton Competitive Strengths & Weaknesses
Table 149. Piramal Basic Information, Area Served and Competitors
Table 150. Piramal Major Business
Table 151. Piramal Pharmaceutical CDMO Product and Services
Table 152. Piramal Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. Piramal Recent Developments/Updates
Table 154. Piramal Competitive Strengths & Weaknesses
Table 155. Strides Pharma Basic Information, Area Served and Competitors
Table 156. Strides Pharma Major Business
Table 157. Strides Pharma Pharmaceutical CDMO Product and Services
Table 158. Strides Pharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Strides Pharma Recent Developments/Updates
Table 160. Strides Pharma Competitive Strengths & Weaknesses
Table 161. NextPharma Basic Information, Area Served and Competitors
Table 162. NextPharma Major Business
Table 163. NextPharma Pharmaceutical CDMO Product and Services
Table 164. NextPharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. NextPharma Recent Developments/Updates
Table 166. NextPharma Competitive Strengths & Weaknesses
Table 167. Famar Basic Information, Area Served and Competitors
Table 168. Famar Major Business
Table 169. Famar Pharmaceutical CDMO Product and Services
Table 170. Famar Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Famar Recent Developments/Updates
Table 172. Famar Competitive Strengths & Weaknesses
Table 173. Jubilant Basic Information, Area Served and Competitors
Table 174. Jubilant Major Business
Table 175. Jubilant Pharmaceutical CDMO Product and Services
Table 176. Jubilant Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 177. Jubilant Recent Developments/Updates
Table 178. Jubilant Competitive Strengths & Weaknesses
Table 179. Alcami Basic Information, Area Served and Competitors
Table 180. Alcami Major Business
Table 181. Alcami Pharmaceutical CDMO Product and Services
Table 182. Alcami Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 183. Alcami Recent Developments/Updates
Table 184. Alcami Competitive Strengths & Weaknesses
Table 185. Euroapi Basic Information, Area Served and Competitors
Table 186. Euroapi Major Business
Table 187. Euroapi Pharmaceutical CDMO Product and Services
Table 188. Euroapi Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 189. Euroapi Recent Developments/Updates
Table 190. Euroapi Competitive Strengths & Weaknesses
Table 191. Eurofins Basic Information, Area Served and Competitors
Table 192. Eurofins Major Business
Table 193. Eurofins Pharmaceutical CDMO Product and Services
Table 194. Eurofins Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 195. Eurofins Recent Developments/Updates
Table 196. Eurofins Competitive Strengths & Weaknesses
Table 197. Avid Bioservices Basic Information, Area Served and Competitors
Table 198. Avid Bioservices Major Business
Table 199. Avid Bioservices Pharmaceutical CDMO Product and Services
Table 200. Avid Bioservices Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 201. Avid Bioservices Recent Developments/Updates
Table 202. Avid Bioservices Competitive Strengths & Weaknesses
Table 203. BioVectra Basic Information, Area Served and Competitors
Table 204. BioVectraMajor Business
Table 205. BioVectra Pharmaceutical CDMO Product and Services
Table 206. BioVectra Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 207. BioVectra Recent Developments/Updates
Table 208. CPL Basic Information, Area Served and Competitors
Table 209. CPL Major Business
Table 210. CPL Pharmaceutical CDMO Product and Services
Table 211. CPL Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 212. Global Key Players of Pharmaceutical CDMO Upstream (Raw Materials)
Table 213. Pharmaceutical CDMO Typical Customers
LIST OF FIGURES
Figure 1. Pharmaceutical CDMO Picture
Figure 2. World Pharmaceutical CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical CDMO Markets in 2022
Figure 27. United States VS China: Pharmaceutical CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical CDMO Market Size Market Share by Type in 2022
Figure 31. API CDMO
Figure 32. FDF CDMO
Figure 33. Packaging CDMO
Figure 34. Clinical CDMO
Figure 35. World Pharmaceutical CDMO Market Size Market Share by Type (2018-2029)
Figure 36. World Pharmaceutical CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Pharmaceutical CDMO Market Size Market Share by Application in 2022
Figure 38. Pharmaceutical Company
Figure 39. Biotechnology Company
Figure 40. Other
Figure 41. Pharmaceutical CDMO Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Pharmaceutical CDMO Picture
Figure 2. World Pharmaceutical CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical CDMO Markets in 2022
Figure 27. United States VS China: Pharmaceutical CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical CDMO Market Size Market Share by Type in 2022
Figure 31. API CDMO
Figure 32. FDF CDMO
Figure 33. Packaging CDMO
Figure 34. Clinical CDMO
Figure 35. World Pharmaceutical CDMO Market Size Market Share by Type (2018-2029)
Figure 36. World Pharmaceutical CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Pharmaceutical CDMO Market Size Market Share by Application in 2022
Figure 38. Pharmaceutical Company
Figure 39. Biotechnology Company
Figure 40. Other
Figure 41. Pharmaceutical CDMO Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
